David Rosenberg, M.D., the interim Chair of the Wayne State University School of Medicine's Department of Psychiatry and Behavioral Neurosciences, is the lead author and editor of "Pharmacotherapy of Child and Adolescent Psychiatric Disorders, 3rd Edition."

The book serves as an important tool for health professionals involved in the care of children and adolescents with major psychiatric disorders.

"This is the third edition of the first-ever book published in pediatric psychopharmacology and fulfills an urgent need for an updated text on pediatric psychopharmacology, taking a unique approach in the context of economic and political issues," said Dr. Rosenberg, the Miriam L. Hamburger Endowed Chair of Child Psychiatry for WSU and Chief of Child Psychiatry and Psychology at Children's Hospital of Michigan. "Now there is 'competition' in the form of other textbooks. In fact, I have contributed chapters to the other textbooks. This is actually a really good thing and underscores how pediatric psychopharmacology is coming of age."

Dr. Rosenberg said that the book, originally published in 1994, is considered a physician's reference, but has practical applications for psychologists, nurses, nurse practioners, social workers, residents and medical students.

Published by Wiley-Blackwell, "Pharmacotherapy of Child and Adolescent Psychiatric Disorders, 3rd Edition" will be available in February. The latest edition incorporates current developments regarding selective serotonin re-uptake inhibitors, their indications and their safety issues, including possible associated suicidal behavior. The book also addresses cardiovascular side effects of new stimulant medications available and provides comparisons to other FDA-approved medications for attention deficit hyperactivity disorder.